WaBio.com News Analysis Archive

• There's Gold in Them Thar Molecular Tailings
  JPMorgan Healthcare Conference, January 2004
• Remarks by the President
  BIO 2003, June 23, 2003
• Five Ways To Kill the Biotechnology Industry
  Biotechnica America Conference, May 2003
• A Concept: through good old fashion American audacity, let the malaise be over
  JPMorgan Healthcare Conference, January 2003
• Innovation needed: from clinic to approval to the nurses that administer new therapeutics
  JPMorgan Healthcare Conference, January 2003
• Value: the good, the bad and the scary – biotech
  JPMorgan Healthcare Conference, January 2003
• Interview with Greg Sessler, Chair, WBBA, & Ruth Scott, President, WBBA
  WaBio.com, January 2003
• Interview Carl Feldbaum, President, BIO
  WBBA Annual Meeting, October 2002
• Interview with WBBA Chairman: Mike Martino
  WaBio.com, March 2002
• Merger & acquisition: just another corporate reorganization cycle?
  J.P Morgan H&Q, 2002
• Manufacturing Biologics: production capacity as investment criteria
  J.P Morgan H&Q, 2001
• Medical Technologies: boomers embrace quality of life solutions
  J.P Morgan H&Q, 2001
• Drug Costs: a Function of Perspective
  J.P Morgan H&Q, 2001
• Now what? The momentum investors are at your door!
  J.P Morgan H&Q, 2001
• 1999. It was a very good year.
  J.P Morgan H&Q, 2000
• Independence from innovation
  J.P Morgan H&Q, 2000
• At the cutting edge of the new economy: Chase Hambrecht & Quist
  J.P Morgan H&Q, 2000
• From the Buena Vista to the Hambrecht & Quist Healthcare conference: a crossroads of two constants
  J.P Morgan H&Q, 2000
• Free speech and safety as choices, but at what cost?
  BIO 2001
• How to interact with the public: lessons from a TV science reporter regarding GMO
  BIO 2001
• When is a secret better than a patent?
  BIO 2001
• Just what are the components in the biofunding mix?
  BIO 2001

Back to WaBio.com News